Deep Track Capital, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Deep Track Capital, Lp disclosed 57 stock positions valued at approximately $6.79B as of quarter-end June 30, 2026. The largest holdings include GUARDANT HEALTH INC, IMMUNOVANT INC, and STRUCTURE THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 57
- Portfolio Value
- $6.79B
Holdings by Sector
Deep Track Capital, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | GH | Healthcare | 7.50% | 3,393,312 | +55,071 | +1.65% | $509,098,599 |
| IMMUNOVANT INC | IMVT | Healthcare | 5.30% | 9,341,151 | -2,185,820 | -18.96% | $359,914,548 |
| STRUCTURE THERAPEUTICS INC | GPCR | Healthcare | 3.75% | 4,740,072 | +460,224 | +10.75% | $254,399,664 |
| VAXCYTE INC | PCVX | Healthcare | 3.68% | 4,300,000 | - | - | $249,959,000 |
| ALNYLAM PHARMACEUTICALS INC | ALNY | Healthcare | 3.66% | 825,000 | +825,000 | +100.00% | $248,349,750 |
| TARSUS PHARMACEUTICALS INC | TARS | Healthcare | 3.40% | 3,666,768 | +66,768 | +1.85% | $230,786,378 |
| NUVALENT INC | NUVL | Healthcare | 3.24% | 1,783,322 | +406,998 | +29.57% | $220,240,267 |
| ALKERMES PLC | ALKS | Healthcare | 3.09% | 4,000,000 | +409,677 | +11.41% | $209,580,000 |
| OCULAR THERAPEUTIX INC | OCUL | Healthcare | 2.85% | 19,686,282 | - | - | $193,319,289 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 2.79% | 3,307,481 | +2,157,481 | +187.61% | $189,254,063 |
| NURIX THERAPEUTICS INC | NRIX | Healthcare | 2.76% | 7,736,455 | +1,391,211 | +21.93% | $187,686,398 |
| ALUMIS INC | ALMS | Healthcare | 2.63% | 6,348,558 | -424,037 | -6.26% | $178,648,422 |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 2.57% | 2,200,000 | +250,000 | +12.82% | $174,438,000 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 2.54% | 12,161,496 | - | - | $172,085,168 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 2.53% | 4,000,000 | -106,067 | -2.58% | $171,640,000 |
| AXSOME THERAPEUTICS INC. | AXSM | Healthcare | 2.52% | 700,000 | -400,000 | -36.36% | $171,339,000 |
| GENMAB A/S | GMAB | Healthcare | 2.29% | 5,650,000 | +1,986,750 | +54.23% | $155,205,500 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 2.01% | 6,999,025 | +590,162 | +9.21% | $136,271,017 |
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 1.93% | 4,200,000 | +1,450,000 | +52.73% | $131,292,000 |
| DEFINIUM THERAPEUTICS INC | DFTX | Other | 1.91% | 2,750,000 | -250,000 | -8.33% | $129,360,000 |
| GRAIL INC | GRAL | Healthcare | 1.85% | 1,834,944 | +112,147 | +6.51% | $125,271,627 |
| BICARA THERAPEUTICS INC | BCAX | Other | 1.79% | 4,100,000 | +37,500 | +0.92% | $121,729,000 |
| MAZE THERAPEUTICS INC | MAZE | Other | 1.64% | 3,732,569 | +255,007 | +7.33% | $111,379,859 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 1.61% | 2,939,151 | +1,655,172 | +128.91% | $109,365,809 |
| LB PHARMACEUTICALS INC | LBRX | Other | 1.60% | 3,352,804 | - | - | $108,815,254 |
| MBX BIOSCIENCES INC | MBX | Other | 1.41% | 1,732,569 | -1,025,000 | -37.17% | $95,637,809 |
| GH RESEARCH PLC | GHRS | Other | 1.32% | 3,333,334 | +3,333,334 | +100.00% | $89,600,018 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 1.14% | 2,000,000 | +1,000,000 | +100.00% | $77,400,000 |
| UNITED THERAPEUTICS CORP DEL | UTHR | Healthcare | 0.99% | 123,616 | +123,616 | +100.00% | $66,978,857 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 0.98% | 3,610,000 | +3,610,000 | +100.00% | $66,712,800 |
Showing 30 of 57 holdings in the latest reporting period.
Deep Track Capital, Lp Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | GMAB | Genmab A/S | CALL | 3,000,000 | $82,410,000 |
Showing 1 of 1 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.